146 related articles for article (PubMed ID: 7678497)
1. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin.
Humphries JE; Vasudevan J; Gonias SL
Arterioscler Thromb; 1993 Jan; 13(1):48-55. PubMed ID: 7678497
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
Hall SW; Humphries JE; Gonias SL
J Biol Chem; 1991 Jul; 266(19):12329-36. PubMed ID: 1712017
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
Anonick PK; Yoo JK; Webb DJ; Gonias SL
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
[TBL] [Abstract][Full Text] [Related]
6. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
Anonick PK; Gonias SL
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
[TBL] [Abstract][Full Text] [Related]
7. Binding of anisoylated Lys-plasminogen streptokinase activator complex to cells in culture.
Vasudevan J; Humphries JE; Gonias SL
Thromb Haemost; 1993 Apr; 69(4):370-4. PubMed ID: 8388580
[TBL] [Abstract][Full Text] [Related]
8. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
9. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
Ries M; Zenker M
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of plasmin by fibrinogen.
Higazi AA; Mayer M
Biochem J; 1990 Jul; 269(2):299-302. PubMed ID: 2143650
[TBL] [Abstract][Full Text] [Related]
11. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
Silence K; Collen D; Lijnen HR
J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
[TBL] [Abstract][Full Text] [Related]
12. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
Reddy KN; Cercek B; Lew AS; Ganz W
Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
[TBL] [Abstract][Full Text] [Related]
13. Enhanced in vitro fibrinolytic activity of immobilized plasmin on collagen beads.
Shankar H; Senatore F; Zuniga P; Venkataramani E
J Biomed Mater Res; 1987 Jul; 21(7):897-912. PubMed ID: 2440893
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
[TBL] [Abstract][Full Text] [Related]
15. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
17. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
Weitz JI; Leslie B; Hirsh J; Klement P
J Clin Invest; 1993 Apr; 91(4):1343-50. PubMed ID: 7682569
[TBL] [Abstract][Full Text] [Related]
18. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion.
Takahashi H; Tatewaki W; Wada K; Niwano H; Hanano M; Shibata A
Am J Hematol; 1991 Apr; 36(4):255-8. PubMed ID: 1826408
[TBL] [Abstract][Full Text] [Related]
19. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
Reed GL; Matsueda GR; Haber E
Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
[TBL] [Abstract][Full Text] [Related]
20. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
Weisdorf DJ; Aldridge JH
Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
